Profil bibliographique

Thomas Spires

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

53Publications signalées

1354Citations signalées

2Affiliations récentes

Institutions déclarées

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Sweden)

Domaines associés

Prostate Cancer Treatment and ResearchEstrogen and related hormone effectsCancer Immunotherapy and BiomarkersPhagocytosis and Immune RegulationHormonal and reproductive studies

Publications récentes

Accès ouvert 2025 articleOpenAlex

Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial

Sherene Loi, Roberto Salgado, Giuseppe Curigliano, Roberto Iván Romero Díaz et autres

0 citationsFuture Oncology

Accès ouvert 2025 articleOpenAlex

Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial

Sherene Loi, Roberto Salgado, Giuseppe Curigliano, Roberto Iván Romero Díaz et autres

117 citationsNature Medicine

Accès ouvert 2024 articleOpenAlex

LBA53 Nivolumab (NIVO) plus relatlimab with platinum-doublet chemotherapy (PDCT) vs NIVO + PDCT as first-line (1L) treatment (tx) for stage IV or recurrent NSCLC: Results from the randomized phase II RELATIVITY-104 study

N. Girard, Mauricio Burotto, L.G. Paz-Ares, Martin Reck et autres

21 citationsAnnals of Oncology

2024 conference-abstractOpenAlex

Abstract GS01-01: Biomarker Results in High-risk Estrogen Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Primary Breast Cancer Following Neoadjuvant Chemotherapy ± Nivolumab: an Exploratory Analysis of CheckMate 7FL

Sherene Loi, Giuseppe Curigliano, Roberto Salgado, Roberto Iván Romero Díaz et autres

24 citationsCancer Research

Accès ouvert 2023 otherOpenAlex

Data from Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra, Sushil Kumar, Ke Geng, David Calianese et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Data from Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra, Sushil Kumar, Ke Geng, David Calianese et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figure S1 from Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed Younes, Hampartsoum B. Barsoumian, Michael Quigley et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figure S2 from Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed Younes, Hampartsoum B. Barsoumian, Michael Quigley et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figure S3 from Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed Younes, Hampartsoum B. Barsoumian, Michael Quigley et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figure S2 from Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed Younes, Hampartsoum B. Barsoumian, Michael Quigley et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figure S3 from Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed Younes, Hampartsoum B. Barsoumian, Michael Quigley et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figure S1 from Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed Younes, Hampartsoum B. Barsoumian, Michael Quigley et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.